GLAXOSMITHKLINE TO SET UP EUR 100 M VACCINE PLANT IN HUNGARY

GlaxoSmithKline (GSK), one of Hungary's largest investors in the drugs industry, is to set up a high-tech vaccine production facility in Gödöllõ, 30 kilometres northeast of Budapest. GSK's EUR 100 million investment is one of the company's key strategic investments in Europe. Portfolio.hu (http://www.portfolio.hu/en/cikkek.tdp?cCheck=1&k=2&i=9415)